Features of the upper respiratory tract microbiota in bacterial carriage of Streptococcus pneumoniae in patients with metabolic syndrome
- Authors: Starikova V.A.1, Konstantinov D.Y.1, Konstantinova E.A.1
-
Affiliations:
- Samara State Medical University
- Issue: Vol 103, No 1 (2026)
- Pages: 86-92
- Section: ORIGINAL RESEARCHES
- URL: https://microbiol.crie.ru/jour/article/view/18938
- DOI: https://doi.org/10.36233/0372-9311-753
- EDN: https://elibrary.ru/FFLKVS
- ID: 18938
Cite item
Abstract
Introduction. The human upper respiratory tract represents a complex ecosystem in dynamic equilibrium with its microbiota. Homeostasis of this system is maintained by multiple factors, including competitive interactions among microorganisms. Disruption of this balance by external or internal factors can lead to dysbiosis, increasing the risk of respiratory and systemic diseases.
Aim. To study the effect of metabolic syndrome in carriers of Streptococcus pneumoniae on the composition of the upper respiratory tract microbiota community.
Materials and methods. A prospective case-control study was conducted, involving 171 S. pneumoniae carriers, of which 118 patients had metabolic syndrome (MetS) and 53 comprised the control group.
Results. It was found that in the presence of MetS, the proportion of individuals with a high degree of nasopharyngeal bacterial colonization was significantly higher (43.2% vs. 15.0%, p < 0.001). The nasopharyngeal microbiota of patients with MetS was characterized by a decreased abundance of commensal taxa Corynebacterium accolens and Dolosigranulum pigrum alongside an increased proportion of opportunistic microorganisms (Haemophilus parainfluenzae, Moraxella catarrhalis, Staphylococcus aureus). In the oropharynx of patients with MetS, a shift towards increased abundance of Gram-negative bacteria (Neisseria subflava, H. parainfluenzae) and opportunistic species (Fusobacterium nucleatum) was observed.
Conclusion. The obtained results demonstrate a link between metabolic disorders and dysbiotic changes in the respiratory tract microbial community and highlight the necessity of considering MetS when developing preventive strategies against pneumococcal infections.
Full Text
Introduction
The human upper respiratory tract (URT) is a complex ecosystem that exists in dynamic equilibrium with the microbiota [1, 2]. The homeostasis of this system is maintained by a variety of factors, including mucociliary clearance, secretion of antimicrobial peptides (e.g., defensins, lysozyme), immune surveillance (IgA, macrophages, neutrophils), and competitive interactions between microorganisms [3, 4]. Disruption of this balance caused by external (infections, antibiotics) or internal (metabolic, immune disorders) factors can lead to dysbiosis, increasing the risk of respiratory and systemic diseases [5, 6].
Normally, the microbiota of the URT is represented by commensal bacteria that suppress the colonization of pathogens by competing for resources and producing bacteriocins [7, 8]. However, when conditions change (e.g., decreased local immunity, inflammation), opportunistic microorganisms (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus) capable of causing infections begin to predominate [9, 10].
S. pneumoniae colonizes the nasopharynx of 20–60% of healthy adults [11], while remaining the leading pathogens of invasive infections, including pneumonia, meningitis, and acute otitis media [12–14]. The level and duration of its carriage are determined by the complex interaction of three key factors. First, competitive interaction with other members of the microbiota is critical. For example, S. aureus is capable of suppressing pneumococcal colonization [15], while H. influenzae competes for the same epithelial cell receptors [16]. Second, the immune status of the macroorganism has a significant impact. It has been established that secretory IgA deficiency is associated with an increased frequency and density of S. pneumoniae colonization [17]. Finally, systemic factors, including metabolic disorders, play an important role. A number of studies demonstrate a link between obesity, diabetes mellitus, dyslipidemia, and changes in the nature of pneumococcal carriage [18, 19]. This complex nature of interactions makes the study of S. pneumoniae carriage particularly relevant for understanding the pathogenesis of respiratory infections and developing preventive strategies.
Despite significant progress in studying the relationship between gut microbiota and metabolic syndrome (MetS) [20], the impact of this pathological condition on respiratory tract microbial communities remains insufficiently studied. Currently, there are no comprehensive studies in the scientific literature that directly demonstrate the relationship between MetS and the characteristics of S. pneumoniae colonization, as well as the accompanying changes in the composition of the respiratory microbiota.
Of particular scientific interest is the question of S. pneumoniae carriage in patients with MetS [21, 22], as well as the composition of the URT microbial community [6, 10]. Furthermore, the task of identifying reliable biomarkers of dysbiotic changes in the microbiota of the URT in patients with metabolic disorders remains relevant [23, 24].
The aim - to study the effect of metabolic syndrome in carriers of Streptococcus pneumoniae on the composition of the upper respiratory tract microbiota community
Materials and methods
A prospective case-control study was conducted. It included 171 S. pneumoniae carriers, who were divided into two groups: group 1 — 118 patients with MetS; group 2 — 53 patients without MetS. The study was conducted with the voluntary informed written consent of the patients. The study protocol was approved by the Ethics Committee of Samara State Medical University (Protocol No. 254 dated September 28, 2022).
The diagnosis of MetS was established according to the modified criteria of the International Diabetes Federation, which included the presence of abdominal obesity (waist circumference ≥ 94 cm for men and ≥ 80 cm for women) in combination with two or more additional criteria: hypertension (blood pressure ≥ 130/85 mmHg or antihypertensive therapy), fasting hyperglycemia (glucose ≥ 5.6 mmol/L) or insulin resistance (HOMA-IR ≥ 2.5), as well as dyslipidemia (triglycerides ≥ 1.7 mmol/L or high-density lipoproteins < 1.0 mmol/L for men/< 1.3 mmol/L for women).
Inclusion criteria:
- age ≥ 21 to 55 years;
- confirmed carriage of pneumoniae;
- absence of antibiotic therapy within 90 days prior to sample collection;
- no history of vaccination against pneumococcal infection;
- no chronic lung disease (chronic obstructive pulmonary disease, bronchial asthma), immunosuppression (HIV) or acute infections when included into the study;
- no exacerbation of chronic infections;
- no active herpes infection;
- no history of glucocorticosteroid use.
Clinical material was collected using sterile swabs with Amies transport medium. A swab was taken from the oropharynx and nasopharynx of each participant. The swabs were immediately delivered to the laboratory within 2 hours for further processing. The samples were seeded on 5% blood agar and selective blood agar with gentamicin added. The plates were incubated in 5% CO2 at 37°C for 24–48 hours. Presumptive identification of colonies morphologically similar to S. pneumoniae was based on characteristic alpha-hemolysis, sensitivity to optochin, and the presence of a lysis reaction with 10% bile.
Species identification of all isolates was confirmed by mass spectrometry (MALDI-TOF MS). The results were interpreted in accordance with the manufacturer's recommendations (logarithmic score ≥ 2.0 for reliable species-level identification). The number of CFU/swab was determined by serial dilutions.
The degree of colonization was classified as:
- low: 101–102 CFU/swab;
- medium: 103–104 CFU/swab;
- high: 105–106 CFU/swab.
In the second stage, high-throughput sequencing of the 16S rRNA gene was used for taxonomic analysis of the microbiota of the upper respiratory tract. Total genomic DNA was extracted from clinical samples using commercial reagent kits. Amplification of the hypervariable regions V3–V4 of the 16S rRNA gene was performed using universal primers, followed by library preparation and sequencing on the Illumina platform in accordance with the manufacturer's standard protocols.
Bioinformatics data processing was performed using standard bioinformatics protocols. After quality control, clustering into operational taxonomic units was performed with a similarity threshold of 97%. Taxonomic identification was performed using 16S rRNA reference databases.
Quantitative indicators between groups were compared using parametric and nonparametric criteria, and qualitative variables were analyzed using the χ² criterion. Statistical significance was determined at a level of p < 0.05.
Results
Analysis of the quantitative level of S. pneumoniae colonization revealed differences between the groups examined. In group 1, low colonization (10¹–10² CFU/swab) was detected in 24 (20.3%) individuals, moderate colonization (10³–10⁴ CFU/swab) in 43 (35.6%), and high colonization (10⁵–10⁶ CFU/swab) in 51 (43.2%) individuals; in the second group, these figures were 27 (51%), 18 (34%), and 8 (15%), respectively. A comparative analysis showed that the proportion of individuals with a high degree of bacterial colonization in the MetS group was statistically significantly higher than in the control group (χ2 = 16.6; p < 0.001).
Nasopharyngeal microbiota
Analysis of the composition of the nasopharyngeal microbiota in individuals carrying S. pneumoniae revealed differences between groups with and without MetS. In both groups, the nasopharyngeal microbiota was predominantly composed of Firmicutes, Actinobacteriota, and Proteobacteria, but their relative proportions differed significantly. In patients in group 2, Firmicutes (35%) and Actinobacteriota (28%) dominated, while in patients in group 1, there was a shift toward an increase in the proportion of Proteobacteria (36% vs. 22%; p < 0.01) with a simultaneous decrease in Actinobacteriota (16% vs. 28%; p < 0.01). The proportion of Firmicutes in MetS was slightly lower (30% vs. 35%), but the difference was not statistically significant.
Analysis at the genus level showed that in individuals in group 2, the leading taxa were Streptococcus (20%), Corynebacterium (18%), and Dolosigranulum (10%), which are associated with colonization resistance and a stable microbial ecosystem. In group 1, there was a significant decrease in the content of Corynebacterium (9% vs. 18%; p < 0.01) and Dolosigranulum (4% vs. 10%; p < 0.01) against the background of an increase in Moraxella (18% vs. 12%; p = 0.02), Haemophilus (12% vs. 8%; p = 0.04), and Staphylococcus (8% vs. 4%; p = 0.05).
Analysis of 16S rRNA sequencing followed by taxonomic assignment allowed us to characterize the microbial community of the nasopharynx. In a number of taxa, species identification was possible with a high degree of reliability. Both commensal and opportunistic microorganisms were identified in the analyzed samples of both groups. Among the dominant taxa identified to the species level in individuals of the second group were S. mitis (18.6%), Corynebacterium accolens (18.4%), D. pigrum (14.1%), and M. catarrhalis (12.6%). Less represented were H. parainfluenzae (10.3%), S. aureus (9.2%), and Neisseria subflava (9.9%). It should be noted that the accuracy of species identification based on the 16S rRNA gene varies for a number of closely related bacteria (e.g., representatives of the S. mitis/pneumoniae/oralis complex); this approach does not always allow for unambiguous species differentiation. The microbial profile of group 1 was characterized by a significant increase in the proportion of opportunistic pathogens for which species identification was achieved. Among them, the most common were S. mitis (21.9%; p = 0.041), M. catarrhalis (17.5%; p = 0.033), H. parainfluenzae (15.2%; p = 0.027), and S. aureus (14.8%; p = 0.039). The proportion of C. accolens (11.7%; p = 0.045) and D. pigrum (9.8%; p = 0.038) was lower than in individuals without MetS, while N. subflava accounted for 9.1% (p = 0.062) (Fig. 1).
Fig. 1. Taxonomic composition of the nasopharynx microbiota at the species level in patients in groups 1 (outer circle) and 2 (inner circle), %.
Oropharyngeal microbiota
Analysis of the structure of the microbial community of the oropharynx at the species level showed that Firmicutes, Bacteroidetes and Proteobacteria dominated in both groups. In group 2, the proportions of these taxa were 52.4, 25.7 and 18.3%, respectively, and in group 1, they were 48.1, 20.2 and 27.9%. Thus, participants with MetS showed a relative increase in Proteobacteria and a decrease in Bacteroidetes, which is consistent with the literature data on dysbiotic changes in metabolic disorders.
At the genus level, Streptococcus (38.5%), Prevotella (19.6%), and Veillonella (14.8%) predominated in individuals without MetS, forming a structure characteristic of conditionally healthy oropharyngeal microbiota. In individuals with MetS, there was a shift towards an increase in the proportion of Haemophilus (17.4%) and Neisseria (15.9%) with a relative decrease in Prevotella to 12.1%, while Streptococcus remained dominant (35.1%).
Analysis of 16S rRNA allowed for detailed characterization of the oropharyngeal microbiota, revealing the presence of both commensal and opportunistic microorganisms, some of which were reliably identified to species level. In patients with MetS, the dominant taxa identified at the species level were predominantly N. subflava (18.2% vs. 14.7% in individuals without MetS; p = 0.04) and H. parainfluenzae (15.5% vs. 13.2%; p = 0.05), which may indicate a tendency toward an increase in the proportion of Gram-negative microorganisms. Opportunistic pathogens such as Fusobacterium nucleatum (8.4% vs. 6.8%; p = 0.03) were also more frequently identified in the MetS group (Fig. 2). It should be noted that the accuracy of species identification based on the 16S rRNA gene varies: for a number of closely related bacteria (e.g., representatives of the Streptococcus genus or various species of Neisseria), this approach does not always allow for unambiguous species differentiation.
Fig. 2. Taxonomic composition of the oropharynx microbiota at the species level in patients in groups 1 (outer circle) and 2 (inner circle), %.
Fig. 2. Taxonomic composition of the oropharynx microbiota at the species level in patients in groups 1 (outer circle) and 2 (inner circle), %.
At the same time, individuals without MetS had a slightly higher average relative abundance of Gemella haemolysans (14.5% vs. 12.1%; p = 0.12), Granulicatella adiacens (10.3% vs. 9.1%; p = 0.20), and Leptotrichia buccalis (7.6% vs. 6.1%; p = 0.07), although these differences did not reach statistical significance.
Discussion
Our study shows that S. pneumoniae carriers with a higher bacterial load were significantly more common in the group of patients with MetS. It is known that high colonization density increases the risk of pneumococcal transmission and the development of invasive forms of infection [25]. The results obtained suggest that metabolic disorders accompanied by chronic inflammation and reduced effectiveness of local immune barriers create conditions for more intense pneumococcal persistence [26].
At the same time, patients with MetS were more likely to have colonization not only with S. pneumoniae, but also with other opportunistic microorganisms. This is probably due to the fact that systemic metabolic disorders, such as obesity, insulin resistance, and dyslipidemia, indirectly affect the microbial community of the upper respiratory tract by weakening the barrier function of the mucous membranes and dysregulating the immune response [19, 27, 28].
In the nasopharynx of patients with MetS, an increase in the proportion of H. parainfluenzae, M. catarrhalis and S. aureus was observed, with a simultaneous decrease in the content of C. accolens and D. pigrum. It is known that C. accolens and D. pigrum are involved in the formation of colonization resistance by inhibiting the growth of pathogens, including pneumococcus [29]. A decrease in the proportion of these protective taxa may reduce the resistance of the microbial community to the introduction of potential pathogens.
N. subflava, H. parainfluenzae and F. nucleatum predominated in the oropharynx of individuals with MetS. A number of studies indicate that F. nucleatum is capable of forming biofilms in the oral cavity and oropharynx [30], contributing to the persistence of pathogens and the maintenance of chronic inflammation.
MetS is characterized by chronic inflammation, hormonal changes (including increased leptin and decreased adiponectin levels), oxidative stress and impaired lipid and carbohydrate metabolism [28]. These factors can alter the expression of mucins and antimicrobial peptides [4] and affect the adhesion and growth of microorganisms on the mucous membranes of the respiratory tract.
Similar changes have been described in studies of the nasopharyngeal microbiota in obese adults, where a decrease in Corynebacterium and Dolosigranulum and an increase in Haemophilus and Moraxella were also observed [23].
The data obtained emphasize the need for further research to assess the impact of MetS on the composition of the upper respiratory tract microbiota.
Conclusion
- Among S. pneumoniae carriers with MetS, the proportion of individuals with a high degree of bacterial colonization of the nasopharynx is higher (43.2% versus 15.0% in the control group).
- The nasopharyngeal microbiota of S. pneumoniae carriers with MetS is characterized by a decrease in the proportion of commensal taxa (Corynebacterium, Dolosigranulum) and an increase in the proportion of opportunistic microorganisms (M. catarrhalis, H. parainfluenzae, S. aureus).
- Analysis of the oropharyngeal microbiota of S. pneumoniae carriers showed that individuals with MetS exhibit signs of dysbiotic changes, manifested by an increase in the proportion of Proteobacteria due to N. subflava and H. parainfluenzae, as well as more frequent detection of opportunistic pathogens, including F. nucleatum. In individuals without MetS, the microbial community was characterized by a large representation of commensal taxa (Gemella haemolysans, Granulicatella adiacens, Leptotrichia buccalis).
About the authors
Valeria A. Starikova
Samara State Medical University
Author for correspondence.
Email: v.a.starikova@samsmu.ru
ORCID iD: 0009-0006-5483-1784
Assistant Professor, Department of infectious diseases with epidemiology
Russian Federation, SamaraDmitry Yu. Konstantinov
Samara State Medical University
Email: d.u.konstantinov@samsmu.ru
ORCID iD: 0000-0002-6177-8487
Dr. Sci. (Med.), Head, Department of infectious diseases with epidemiology
Russian Federation, SamaraElena A. Konstantinova
Samara State Medical University
Email: e.a.konstantinova@samsmu.ru
ORCID iD: 0000-0002-6022-0983
Cand. Sci. (Med.), Associate Professor, Department of infectious diseases with epidemiology
Russian Federation, SamaraReferences
- Лопатин А.С., Азизов И.С., Козлов Р.С. Микробиом полости носа и околоносовых пазух в норме и при патологии. Часть I. Российская ринология. 2021;29(1):23–30. Lopatin A.S., Azizov I.S., Kozlov R.S. Microbiome of the nasal cavity and the paranasal sinuses in health and disease (literature review). Part I. Russian Rhinology. 2021;29(1):23–30. DOI: https://doi.org/10.17116/rosrino20212901123 EDN: https://elibrary.ru/xdzdkb
- Kumpitsch C., Koskinen K., Schöpf V., Moissl-Eichinger C. The microbiome of the upper respiratory tract in health and disease. BMC Biol. 2019;17(1):87. DOI: https://doi.org/10.1186/s12915-019-0703-z
- Sethi S., Murphy T.F. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 2008;359(22):2355–65. DOI: https://doi.org/10.1056/nejmra0800353
- Belkaid Y., Harrison O.J. Homeostatic immunity and the microbiota. Immunity. 2017;46(4):562–76. DOI: https://doi.org/10.1016/j.immuni.2017.04.008
- Шахматова А.А., Шитова И.А., Антонова Е.И. Микробиом респираторного тракта при острых респираторных заболеваниях. В кн.: Фундаментальные и прикладные исследования по приоритетным направлениям биоэкологии и биотехнологии: материалы VI Всероссийской научно-практической конференции с международным участием. Чебоксары;2023:90–8. Shakhmatova A.A., Shitova I.A., Antonova E.I. Microbiome of the respiratory tract in acute respiratory diseases. In: Fundamental and Applied Research in Priority Areas of Bioecology and Biotechnology: Proceedings of the VI All-Russian Scientific and Practical Conference with International participation. Cheboksary;2023:90–8. DOI: https://doi.org/10.31483/r-107071 EDN: https://elibrary.ru/syisek
- Старикова Е.В., Галеева Ю.С., Ильина Е.Н. Роль микробиома верхних дыхательных путей в здоровье человека: барьерная функция. Пульмонология. 2022;32(6):876–84. Starikova E.V., Galeeva Yu.S., Il'ina E.N. The upper respiratory tract microbiome and its role in human health: barrier function. Pulmonologiya. 2022;32(6):876–84. DOI: https://doi.org/10.18093/0869-0189-2022-32-6-876-884 EDN: https://elibrary.ru/kxisya
- Selva L., Viana D., Regev-Yochay G., et al. Killing niche competitors by remote-control bacteriophage induction. Proc. Natl Acad. Sci. USA. 2009;106(4):1234–8. DOI: https://doi.org/10.1073/pnas.0809600106
- Bassis C.M., Tang A.L., Young V.B., Pynnonen M.A. The nasal cavity microbiota of healthy adults. Microbiome. 2014;2:27. DOI: https://doi.org/10.1186/2049-2618-2-27
- Иванова А.А., Передерий А.А., Попенко А.С. и др. Характеристика микробиома верхних дыхательных путей больных острыми респираторными инфекциями по данным секвенирования гена 16S рРНК. Учёные записки Первого Санкт-Петербургского государственного медицинского университета имени академика И.П. Павлова. 2024;31(4):19–26. Ivanova A.A., Perederiy A.A., Popenko A.S., et al. Characterization of the upper respiratory tract microbiome of patients with acute respiratory infections by 16S rRNA sequencing. The Scientific Notes of the Pavlov University. 2024;31(4):19–26. DOI: https://doi.org/10.24884/1607-4181-2024-31-4-19-26
- Bogaert D., De Groot R., Hermans P.W. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis. 2004;4(3):144–54. DOI: https://doi.org/10.1016/S1473-3099(04)00938-7
- Narciso A.R., Dookie R., Nannapaneni P., et al. Streptococcus pneumoniae epidemiology, pathogenesis and control. Nat. Rev. Microbiol. 2025;23(4):256–71. DOI: https://doi.org/10.1038/s41579-024-01116-z
- Брико Н.И., Коршунов В.А., Ломоносов К.С. Пневмококковая инфекция в Российской Федерации: состояние проблемы. Вестник Российской академии медицинских наук. 2021;76(1):28–42. Briko N.I., Korshunov V.A., Lomonosov K.S. Pneumococcal infection in Russia: state of the issue. Annals of the Russian Academy of Medical Sciences. 2021;76(1):28–42. DOI: https://doi.org/10.15690/vramn1404 EDN: https://elibrary.ru/hxbifk
- Narciso A.R., Dookie R., Nannapaneni P., et al. Streptococcus pneumoniae epidemiology, pathogenesis and control. Nat. Rev. Microbiol. 2025;23(4):256–71. DOI: https://doi.org/10.1038/s41579-024-01116-z
- Diaz-Diaz A., Bunsow E., Garcia-Maurino C., et al. Nasopharyngeal codetection of Haemophilus influenzae and Streptococcus pneumoniae shapes respiratory syncytial virus disease outcomes in children. J. Infect. Dis. 2022;225(5):912–23. DOI: https://doi.org/10.1093/infdis/jiab481
- Fasching C.E., Grossman T., Corthésy B., et al. Impact of the molecular form of immunoglobulin A on functional activity in defense against Streptococcus pneumoniae. Infect. Immun. 2007;75(1):01758–06. DOI: https://doi.org/10.1128/IAI.01758-06
- Hales C., Burnet L., Coombs M., et al. Obesity, leptin and host defence of Streptococcus pneumoniae: the case for more human research. Eur. Respir. Rev. 2022;31(165):220055. DOI: https://doi.org/10.1183/16000617.0055-2022
- Silverii G.A., Gabutti G., Tafuri S., et al. Diabetes as a risk factor for pneumococcal disease and severe related outcomes and efficacy/effectiveness of vaccination in diabetic population. Results from meta-analysis of observational studies. Acta Diabetol. 2024;61(8):1029–39. DOI: https://doi.org/10.1007/s00592-024-02282-5
- Krznarić J., Vince A. The role of non-alcoholic fatty liver disease in infections. Life (Basel). 2022;12(12):2052. DOI: https://doi.org/10.3390/life12122052
- Acierno C., Nevola R., Barletta F., et al. Multidrug-resistant infections and metabolic syndrome: an overlooked bidirectional relationship. Biomedicines. 2025;13(6):1343. DOI: https://doi.org/10.3390/biomedicines13061343
- Prince Y., Davison G.M., Davids S.F.G., et al. The relationship between the oral microbiota and metabolic syndrome. Biomedicines. 2023;11(1):3. DOI: https://doi.org/10.3390/biomedicines11010003
- Quinn-Bohmann N., Freixas-Coutin J.A., Seo J., et al. Meta-analysis of the human upper respiratory tract microbiome reveals robust taxonomic associations with health and disease. BMC Biol. 2024;22(1):93. DOI: https://doi.org/10.1186/s12915-024-01890-5
- Wolter N., Tempia S., Cohen C., et al. High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia. J. Infect. Dis. 2014;210(10):1649–57. DOI: https://doi.org/10.1093/infdis/jiu326
- Sutcliffe C.G., Grant L.R., Cloessner E., et al. Association of laboratory methods, colonization density, and age with detection of Streptococcus pneumoniae in the nasopharynx. Am. J. Epidemiol. 2019;188(12):2110–9. DOI: https://doi.org/10.1093/aje/kwz191
- Cilloniz C., Torres A. Diabetes mellitus and pneumococcal pneumonia. Diagnostics (Basel). 2024;14(8):859. DOI: https://doi.org/10.3390/diagnostics14080859
- Bomar L., Brugger S.D., Yost B.H., et al. Corynebacterium accolens releases antipneumococcal free fatty acids from human nostril and skin surface triacylglycerols. mBio. 2016;7(1):e01725–15. DOI: https://doi.org/10.1128/mBio.01725-15
- Kommerein N., Stumpp N.S., Müsken M., et al. Fusobacterium nucleatum and Candida albicans interact in biofilms and regulate virulence via quorum sensing. Front. Microbiol. 2020;11:271. DOI: https://doi.org/10.3389/fmicb.2020.00271
- Bor B., Cen L., Agnello M., et al. Morphological and physiological changes induced by contact-dependent interaction between Candida albicans and Fusobacterium nucleatum. Sci. Rep. 2016;6:27956. DOI: https://doi.org/10.1038/srep27956
- Tilg H., Moschen A.R., Roden M. NAFLD and diabetes mellitus. Nat. Rev. Gastroenterol. Hepatol. 2017;14(1):32–42. DOI: https://doi.org/10.1038/nrgastro.2016.147
Supplementary files





